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EVIDENCE-BASED ANSWER
 it depends. Simply performing 
 spirometry and off ering cessation 
advice doesn’t improve quit rates in patients 
who smoke (strength of recommendation 
[SOR]: A, systematic review of randomized 
controlled trials [RCTs]). However, when 
the spirometry results are communicated 
in terms of “lung age,” smokers are more 
likely to quit (SOR: B, large RCT). Patients 
with abnormal spirometry results may 
be more likely to quit than patients with 
normal results (SOR: B, cohort studies).
Evidence summary
A systematic review of 3 RCTs with a total of 
649 participants evaluated offi  ce spirometry 
as a motivational tool to improve quit rates by 
comparing spirometry plus cessation advice 
with cessation advice alone. All participants 
were men and women 19 to 75 years of age 
recruited from outpatient clinics.1 
In 1 trial, the intervention group re-
ceived repeated counseling at 4 visits and 
underwent spirometry; the control group had 
1 counseling session and was given a bro-
chure. In the other 2 trials, the intervention 
group had both carbon monoxide measure-
ments and spirometry, and all participants re-
ceived more extensive counseling, including 
cessation skills training. 
At 9 to 12 months’ follow-up, quit rates 
ranged from 6% to 24% in the intervention 
groups vs 5% to 14% in the control groups (not 
signifi cantly diff erent).1 
A subsequent study randomized 221 
smokers to receive either spirometry plus 
brief cessation advice or advice alone. Re-
searchers recruited patients 15 to 80 years 
of age who were willing to quit smoking 
from 16 general practice clinics in Belgium. 
Fifty-one percent of patients in both 
groups used nicotine replacement thera-
py (a larger percentage than is typical in 
studies done in the United States). At 6, 
12, and 24 months, 5%, 2%, and 5% more 
smokers, respectively, from the spirom-
etry group quit smoking compared with the 
control group, but this diff erence was not 
signifi cant.2 
Reporting spirometry results 
in terms of lung age may spur quitting
One RCT found significantly improved quit 
rates when patients who smoked were given 
their office spirometry results in terms of 
“lung age” (the age of an average healthy 
person with similar spirometry results) 
rather than as forced expiratory volume in 
1 second (FEV1). Investigators performed 
office spirometry and gave smoking ces-
sation advice to 561 smokers older than 
35 years who were recruited from 5 gen-
eral practices. They randomized patients 
to receive their spirometry results as either 
lung age or FEV1 and recorded quit rates at 
12 months (smoking cessation was veri-
fied by measuring blood levels of carbon 
monoxide). 
Patients whose spirometry results were 
reported as lung age were signifi cantly more 
likely to quit than smokers whose results were 
given as FEV1 (13.6% vs 6.4%; P=.005; num-
ber needed to treat [NNT]=14 smokers coun-
seled using lung age to cause 1 more patient 
to quit). Smokers with normal lung ages were 
no more likely to quit than smokers with ab-
normal results.3
Simply 
performing 
spirometry and 
offering smoking 
cessation advice 
doesn’t improve 
quit rates.
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Patients with 
moderate to 
severe airﬂ ow 
limitation 
showed 
signiﬁ cantly 
higher quit 
rates when 
compared with 
patients with 
mildly abnormal 
spirometry. 
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Abnormal results also 
may be a motivator 
However, 3 prospective cohort studies dem-
onstrated that patients with abnormal spi-
rometry results were more likely to quit than 
patients with normal spirometry. In the fi rst 
study, 4494 patients with at least 10 pack-years 
of smoking from 10 outpatient chest clinics in 
Poland underwent spirometry and were coun-
seled to quit smoking; 1177 had abnormal spi-
rometry results. 
One year later, 16.3% of smokers with ab-
normal results had quit smoking, compared 
with 12% in the group with normal spirometry 
(P=.0003; NNT=23).4
Th e second study, also at outpatient chest 
clinics in Poland, evaluated spirometry plus 
cessation advice among 558 smokers, 297 of 
whom had abnormal spirometry results. At 1 
year, 10.6% of patients with abnormal results 
had quit, compared with 8.4% of patients with 
normal lung function. A subgroup of 109 pa-
tients with moderate to severe airfl ow limita-
tion showed signifi cantly higher quit rates 
when compared with patients with mildly 
abnormal spirometry (16.5% vs 6.4%; P<.0001; 
NNT=10).5
In the third study, 6 primary care sites in 
Sweden provided spirometry and brief ces-
sation advice to 445 smokers, 119 of whom 
were found to have abnormal lung function. 
At 3-year follow-up, 29% of patients with ab-
normal lung function had quit smoking, com-
pared with 14% of patients with normal lung 
function (P=.001; NNT=7). Forty-fi ve smok-
ers with mildly abnormal lung function were 
recruited from this study to participate in an-
other study, which may have biased the results 
toward higher quit rates among smokers with 
worse spirometry results.6 
Recommendations 
Th e US Preventive Services Task Force recom-
mends against using spirometry to screen for 
chronic obstructive pulmonary disease, but 
advocates screening all adults for tobacco use 
and encouraging cessation.7
Th e authors of a Cochrane review found 
insuffi  cient evidence to recommend using 
biomedical risk assessment (carbon monox-
ide blood levels, spirometry, genetic testing 
for alpha-1 antitrypsin defi ciency) as a smok-
ing cessation aid.8 JFP
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